Evaluation of SV40 in osteosarcoma and healthy population: A Hungarian-German study

Oncology Reports

Volumn 21, Issue 2, 2009, Pages 289-297

  Heinsohn, Susanne ^a   Szendroi, Miklos ^b   Bielack, Stefan ^c,d   Stadt, Udo Zur ^a   Kabisch, Hartmut ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c Department of Oncology Haematology and Immunology   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Large T antigen; Osteosarcoma; Real time quantitative PCR; Simian virus 40

Indexed keywords

GENOMIC DNA; VIRUS DNA;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; EUROPE; FEMALE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; GERMANY; HUMAN; HUMAN CELL; HUMAN TISSUE; HUNGARY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OSTEOSARCOMA; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIMIAN VIRUS 40; VIRUS DETECTION; VIRUS EXAMINATION; VOLUNTEER; ADULT; AGED; BONE TUMOR; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; DNA, VIRAL; FEMALE; GERMANY; HUMANS; HUNGARY; MALE; MIDDLE AGED; OSTEOSARCOMA; POLYOMAVIRUS INFECTIONS; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40; TUMOR VIRUS INFECTIONS;

EID: 62849088644     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000220     Document Type: Article

References (49)

1. Scholz RB, Kabisch H, Weber B, Roser K, Delling G and Winkler K: Studies of the RB1 gene and the p53 gene in human osteosarcomas. Pediatr Hematol Oncol 9: 125-137, 1992.
2. Scholz RB, Christiansen H, Kabisch H and Winkler K: Molecular markers in the evaluation of bone neoplasms. In: Pathology of Bone and Joint Neoplasms. Helliwell TR (ed). WB Saunders Company, Philadelphia, pp79-105, 1999.
3. Fuchs N and Winkler K: Osteosarcoma. Curr Opin Oncol 5: 667-671, 1993.
4. Mendoza S, Konishi T, Dernell WS, Withrow SJ and Miller CW: Status of the p53, Rb and MDM2 genes in canine osteosarcoma. Anticancer Res 18: 4449-4453, 1998.
5. Szendroi M: Bone tumours. Int Orthop 30: 435-436, 2006.
6. Carbone M, Rizzo P, Procopio A, Giuliano M, Pass HI, Gebhardt MC, Mangham C, Hansen M, Malkin DF, Bushart G, Pompetti F, Picci P, Levine AS, Bergsagel JD and Garcea RL: SV40-like sequences in human bone tumors. Oncogene 13: 527-535, 1996.
7. Lednicky JA, Stewart AR, Jenkins JJ III, Finegold MJ and Butel JS: SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes. Int J Cancer 72: 791-800, 1997.
8. Mendoza SM, Konishi T and Miller CW: Integration of SV40 in human osteosarcoma DNA. Oncogene 17: 2457-2462, 1998.
9. Shah K and Nathanson N: Human exposure to SV40: review and comment. Am J Epidemiol 103: 1-12, 1976.
10. Cicala C, Pompetti F and Carbone M: SV40 induces mesotheliomas in hamsters. Am J Pathol 142: 1524-1533, 1993.
11. Diamandopoulos GT: Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40. Science 176: 173-175, 1972.
12. Diamandopoulos GT and Sanborn-Redmond S: Adenovirus-like transformation of hamster embryo cells mediated by Simian virus 40. Am J Pathol 71: 81-92, 1973.
13. Diamandopoulos GT: Induction of lymphocytic leukemia, lymphosarcoma, reticulum cell sarcoma, and osteogenic sarcoma in the Syrian golden hamster by oncogenic DNA simian virus 40. J Natl Cancer Inst 50: 1347-1365, 1973.
14. Girardi AJ, Sweet BH, Slotnick VB and Hillemann MR: Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV-40. Proc Soc Exp Biol Med 109: 649-660, 1962.
15. Shein HM, Enders JF and Levinthal JD: Transformation induced by simian virus 40 in human renal cell cultures. II. Cellvirus relationships. Proc Natl Acad Sci USA 48: 1350-1357, 1962.
16. Ray FA, Peabody DS, Cooper LJ, Cram LS and Kraemer PM: SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts. J Cell Biochem 42: 13-31, 1990.
17. Crawford LV, Cole CN, Smith AE, Paucha E, Tegtmeyer P, Rundell K and Berg P: Organization and expression of early genes of simian virus 40. Proc Natl Acad Sci USA 75: 117-121, 1978.
18. Carbone M, Rizzo P, Grimley PM, Procopio A, Mew DJ, Shridhar V, de Bartolomeis A, Esposito V, Giuliano MT, Steinberg SM, Levine AS, Giordano A and Pass HI: Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med 3: 908-912, 1997.
19. De Luca A, Baldi A, Esposito V, Howard CM, Bagella L, Rizzo P, Caputi M, Pass HI, Giordano GG, Baldi F, Carbone M and Giordano A: The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat Med 3: 913-916, 1997.
20. Butel JS and Lednicky JA: Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst 91: 119-134, 1999.
21. Fisher SG, Weber L and Carbone M: Cancer risk associated with simian virus 40 contaminated polio vaccine. Anticancer Res 19: 2173-2180, 1999.
22. Fraumeni JF Jr, Ederer F and Miller RW: An evaluation of the carcinogenicity of simian virus 40 in man. JAMA 185: 713-718, 1963.
23. Geissler E: SV40 and human brain tumors. Prog Med Virol 37: 211-222, 1990.
24. Melnick JL and Stinebaugh S: Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine. Proc Soc Exp Biol Med 109: 965-968, 1962.
25. Domok I, Molnar E and Jancso A: Virus excretion after mass vaccination with attenuated polioviruses in Hungary. Br Med J 1: 1410-1417, 1961.
26. Sweet BH and Hilleman MR: The vacuolating virus, S.V. 40. Proc Soc Exp Biol Med 105: 420-427, 1960.
27. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ and Garcea RL: DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 326: 988-993, 1992.
28. Carbone M, Rizzo P and Pass HI: Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene 15: 1877-1888, 1997.
29. Mutti L, Carbone M, Giordano GG and Giordano A: Simian virus 40 and human cancer. Monaldi Arch Chest Dis 53: 198-201, 1998.
30. Weiss R, Giordano A, Furth P, DeCaprio J, Pipas J, Ozer H, Strickler H, Procopio A, Garcea R and Carbone M: SV40 as an oncogenic virus and possible human pathogen. Dev Biol Stand 194: 355-360, 69-82, 1998.
31. Carbone M, Rizzo P and Pass H: Simian virus 40: the link with human malignant mesothelioma is well established. Anticancer Res 20: 875-877, 2000.
32. Gazdar AF, Butel JS and Carbone M: SV40 and human tumours: myth, association or causality? Nat Rev Cancer 2: 957-964, 2002.
33. Garcea RL and Imperiale MJ: Simian virus 40 infection of humans. J Virol 77: 5039-5045, 2003.
34. Vilchez RA, Kozinetz CA, Arrington AS, Madden CR and Butel JS: Simian virus 40 in human cancers. Am J Med 114: 675-684, 2003.
35. Vanchiere JA, White ZS and Butel JS: Detection of BK virus and simian virus 40 in the urine of healthy children. J Med Virol 75: 447-454, 2005.
36. Paracchini V, Garte S, Pedotti P and Taioli E: Review of prevalence of Simian virus 40 (SV40) genomic infection in healthy subjects. Mutat Res 612: 77-83, 2005.
37. Paracchini V, Garte S, Pedotti P, Poli F, Frison S and Taioli E: Molecular identification of Simian virus 40 infection in healthy Italian subjects by birth cohort. Mol Med 11: 48-51, 2005.
38. Lednicky JA, Garcea RL, Bergsagel DJ and Butel JS: Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology 212: 710-717, 1995.
39. Butel JS, Arrington AS, Wong C, Lednicky JA and Finegold MJ: Molecular evidence of simian virus 40 infections in children. J Infect Dis 180: 884-887, 1999.
40. Jasani B, Cristaudo A, Emri SA, Gazdar AF, Gibbs A, Krynska B, Miller C, Mutti L, Radu C, Tognon M and Procopio A: Association of SV40 with human tumours. Semin Cancer Biol 11: 49-61, 2001.
41. Heinsohn S, Scholz RB, Weber B, Wittenstein B, Werner M, Delling G, Kempf-Bielack B, Setlak P, Bielack S and Kabisch H: SV40 sequences in human osteosarcoma of German origin. Anticancer Res 20: 4539-4545, 2000.
42. Heinsohn S, Golta S, Kabisch H and zur Stadt U: Standardized detection of Simian virus 40 by real-time quantitative polymerase chain reaction in pediatric malignancies. Haematologica 90: 94-99, 2005.
43. McNees AL, White ZS, Zanwar P, Vilchez RA and Butel JS: Specific and quantitative detection of human polyomaviruses BKV, JCV, and SV40 by real time PCR. J Clin Virol 34: 52-62, 2005.
44. Butel JS, Wong C, Vilchez RA, Szucs G, Domok I, Kriz B, Slonim D and Adam E: Detection of antibodies to polyomavirus SV40 in two central European countries. Cent Eur J Public Health 11: 3-8, 2003.
45. Gluzman Y: SV40-transformed Simian cells support the replication of early SV40 mutants. Cell 23: 175-182, 1981.
46. Butel JS, Jafar S, Stewart AR and Lednicky JA: Detection of authentic SV40 DNA sequences in human brain and bone tumours. Dev Biol Stand 94: 23-32, 1998.
47. Carbone M, Fisher S, Powers A, Pass HI and Rizzo P: New molecular and epidemiological issues in mesothelioma: role of SV40. J Cell Physiol 180: 167-172, 1999.
48. Weggen S, Bayer TA, von Deimling A, Reifenberger G, von Schweinitz D, Wiestler OD and Pietsch T: Low frequency of SV40, JC and BK polyomavirus sequences in human medullo-blastomas, meningiomas and ependymomas. Brain Pathol 10: 85-92, 2000.
49. Montesinos-Rongen M, Besleaga R, Heinsohn S, Siebert R, Kabisch H, Wiestler OD and Deckertm M: Absence of simian virus 40 DNA sequences in primary central nervous system lymphoma in HIV-negative patients. Virchows Arch 444: 436-438, 2004.